Following the identification of GEFS+ variants, de novo heterozygous SCN1A/NaV1.1 variants have been identified in DS patients (Claes et al., 2001; Dravet, 2011), which is one of the most studied DEE (Guerrini et al., 2023). Here, SCN1A is linked to Dravet syndrome.